Search Results for: Drug development

December 12, 2019December 12, 2019

The right mouse model is crucial for Huntington’s disease drug development

Publication date: Dec 12, 2019 Scientists evaluated the mouse models used for developing new treatments for mood disorders in HD and recommended which of these models are most relevant to ... Read more

December 12, 2019December 12, 2019

Translational Research in Intensive Care Unit: Novel Approaches for Drug Development and Personalized Medicine.

Precision Medicine Literature

Publication date: Oct 01, 2019 The major clinical presentations seen by critical care physicians are sepsis and acute respiratory distress syndrome (ARDS), both of which are heterogeneous clinical syndromes rather ... Read more

December 10, 2019December 10, 2019

Site-agnostic biomarker-guided oncology drug development.

Precision Medicine Literature

Publication date: Dec 07, 2019 Introduction: Advances within molecular diagnostics have enabled us to identify a number of oncogenic drivers across different cancers. Many cancers can now be divided into ... Read more

November 22, 2019November 22, 2019

DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington’s Disease Drug Development

Huntington's Disease News

Publication date: Nov 22, 2019 Most recently the FDA awarded MMJ International Holdings cE2€^3Orphan Drug DesignationcE2€^3 for its THC and CBD proprietary drug formulation which will be used for the ... Read more

November 15, 2019November 15, 2019

Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer.

Precision Medicine Literature

Publication date: Nov 13, 2019 Precision medicine offers opportunities for reducing the costs, burdens, and time associated with drug development. We examined time, number of trials, indications tested and patient ... Read more

November 10, 2019November 10, 2019

MMJ International Holdings Shipping THC and CBD For Clinical Trial Drug Development

Huntington's Disease News

Publication date: Nov 10, 2019 ST PETERSBURG, FL / ACCESSWIRE / November 9, 2019 / MMJ International Holdings, the premier medical cannabis research company, announced that it is awaiting DEA ... Read more

November 9, 2019November 9, 2019

AI in drug development: the FDA needs to set standards

Precision Medicine News

Publication date: Nov 07, 2019 The FDA has an opportunity to ease regulatory uncertainty by proposing a framework that guides how sponsors can use AI tools within drug development programs. ... Read more

November 8, 2019November 8, 2019

A high yielding IFNAR1 ECD mammalian expression process for use in autoimmune disease drug development.

Multiple Sclerosis Literature

Publication date: Nov 02, 2019 Interferon-alpha receptor 1 (IFNAR1) is a target of interest for recombinant biotherapeutics that block the JAK/STAT pathway. This pathway is believed to play a role ... Read more

October 18, 2019October 18, 2019

The NIH microphysiological systems program: developing in vitro tools for safety and efficacy in drug development.

Precision Medicine Literature

Publication date: Oct 14, 2019 Approximately 30% of drugs have failed in human clinical trials due to adverse reactions despite promising pre-clinical studies, and another 60% fail due to lack ... Read more

October 16, 2019October 16, 2019

Precision Medicine: The Function of Receptor Occupancy Assays in Drug Development

Precision Medicine Media

Publication date: Oct 15, 2019 In this video, we discuss different technical approaches that can be used to assess receptor occupancy (RO) by flow cytometry and explore the various pros ... Read more